297 related articles for article (PubMed ID: 28053902)
1. Human papilloma virus in oral cancer.
Kim SM
J Korean Assoc Oral Maxillofac Surg; 2016 Dec; 42(6):327-336. PubMed ID: 28053902
[TBL] [Abstract][Full Text] [Related]
2. Current status of human papillomavirus vaccines.
Kim KS; Park SA; Ko KN; Yi S; Cho YJ
Clin Exp Vaccine Res; 2014 Jul; 3(2):168-75. PubMed ID: 25003090
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer.
Zhai L; Yadav R; Kunda NK; Anderson D; Bruckner E; Miller EK; Basu R; Muttil P; Tumban E
Antiviral Res; 2019 Jun; 166():56-65. PubMed ID: 30926288
[TBL] [Abstract][Full Text] [Related]
4. Human papilloma virus vaccines: Current scenario.
Pandhi D; Sonthalia S
Indian J Sex Transm Dis AIDS; 2011 Jul; 32(2):75-85. PubMed ID: 22021967
[TBL] [Abstract][Full Text] [Related]
5. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
McCormack PL; Joura EA
BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
[TBL] [Abstract][Full Text] [Related]
7. Burden of disease associated with cervical cancer in malaysia and potential costs and consequences of HPV vaccination.
Aljunid S; Zafar A; Saperi S; Amrizal M
Asian Pac J Cancer Prev; 2010; 11(6):1551-9. PubMed ID: 21338196
[TBL] [Abstract][Full Text] [Related]
8. Primary prevention of cervical cancer: prophylactic human papillomavirus vaccines.
Mandic A
J BUON; 2012; 17(3):422-7. PubMed ID: 23033276
[TBL] [Abstract][Full Text] [Related]
9. [Quantitative analysis of nine types of virus-like particles in human papilloma virus bulk by size-exclusion chromatography].
Long Z; Li X; Li X; Liu J; Nie J; Li C; Li Y; Huang T; Huang W
Se Pu; 2021 Apr; 39(4):424-429. PubMed ID: 34227763
[TBL] [Abstract][Full Text] [Related]
10. Genitoanal human papillomavirus infection and associated neoplasias.
Gross G
Curr Probl Dermatol; 2014; 45():98-122. PubMed ID: 24643181
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus, cervical cancer, and the vaccines.
Tovar JM; Bazaldua OV; Vargas L; Reile E
Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus: current status and issues of vaccination.
Malik H; Khan FH; Ahsan H
Arch Virol; 2014 Feb; 159(2):199-205. PubMed ID: 24022639
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic HPV vaccination: past, present, and future.
Castle PE; Maza M
Epidemiol Infect; 2016 Feb; 144(3):449-68. PubMed ID: 26429676
[TBL] [Abstract][Full Text] [Related]
14. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer prevention in the human papilloma virus vaccine era.
Ghazal-Aswad S
Ann N Y Acad Sci; 2008 Sep; 1138():253-6. PubMed ID: 18837904
[TBL] [Abstract][Full Text] [Related]
16. Developing an HPV vaccine to prevent cervical cancer and genital warts.
Bryan JT
Vaccine; 2007 Apr; 25(16):3001-6. PubMed ID: 17289220
[TBL] [Abstract][Full Text] [Related]
17. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
Khaliq SA; Shyum Naqvi SB; Fatima A
Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
[TBL] [Abstract][Full Text] [Related]
18. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study.
Brisson M; Laprise JF; Drolet M; Van de Velde N; Franco EL; Kliewer EV; Ogilvie G; Deeks SL; Boily MC
Vaccine; 2013 Aug; 31(37):3863-71. PubMed ID: 23830974
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
[TBL] [Abstract][Full Text] [Related]
20. The human papillomavirus vaccines.
Ljubojević S
Acta Dermatovenerol Croat; 2006; 14(3):208. PubMed ID: 17010274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
